HAVCR2 and breast carcinoma: Importantly, upregulation of TIM‐3 on TIDC has been reported in lung, bladder, and breast cancer patients,61, 62, 63 and multiple mechanisms of DC immunosuppression are mediated by TIM‐3 within the TME.